Old dogs and new tricks – drug repurposing for rare diseases
In the same week as rare disease day and a summit on CAR-TCR looking at the ‘value’ assessment for incredible new gene and cell therapies...
In the same week as rare disease day and a summit on CAR-TCR looking at the ‘value’ assessment for incredible new gene and cell therapies...
Considerations around ‘value’ assessment for gene and cell therapies in rare diseases was a theme addressed by several speakers, to close...
Dr. Adrian Bot (VP of Translational Medicine – Kite, a Gilead Company) provides an update on the factors determining durable responses...
As a passionate advocate for gene and cell therapies, Fiona Thistlethwaite (Medical Oncology Consultant at The Christie Hospital &...
Really insightful talk delivered by Dr. Mythill Koneru (Chief Medical Officer – Marker Therapeutics) @ the CAR-TCR Summit Europe 2020
A thoughtful overview from Dr Richard Zajicek (Medicine and Process Delivery Leader, GSK) at the CAR-TCR Europe Summit2020, outlining the...
Great talk by Dr. Dalip Sethi (Senior Scientist - Terumo BCT) @ the opening of the CAR-TCR Europe 2020 conference highlighting the many...
As Rare Disease day approaches, it seems timely to reflect on some of what's new in rare disease.
A new scientific paper published...
Imagine being told that you are about to be dropped into a deep and deadly hole with nothing but a grappling hook to pull yourself out....
In pondering the ongoing discoveries and nascent technologies that could advance the treatment of cancer in the coming decade, I am not...
As part of the 2020 European meeting of ISMPP, I attended the Training zone ‘#HITTHEPUBROADRUNNING’, presented by Caroline Halford...
Rare Disease UK hosted the UK’s first ever film festival fully dedicated to raising awareness of rare diseases. Charities, rare disease...
Pondering those cancer circuitry maps such as the one from the updated classic "Hallmarks of Cancer: The Next Generation" by Hanahan and...
Continuing on this theme that Joel has raised in his recent post (“CD19 and BCMA – ‘What if This is as Good as it Gets?’”), I would like...
I’m no fortune-teller. But I can predict with a reasonable amount of certainty that, in the next week or so, we’ll see a press...
I was fortunate enough to spend a day with some of our team, and fellow publications professionals at the 2020 European ISMPP conference.
Ahead of the 6th annual LSX World Congress, Steve Mather, CEO of Cello Health Consulting reflects on supporting an evolving Life Science...
It’s noisy and crowded out there – never has it been so challenging to find novel and cost-effective ways to create an impact with...
As we enter this new decade, it behooves us to both appreciate and laud advances that have been made in Oncology over the past thirty...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net